TY - JOUR
T1 - Parameterization of a drug molecule with a halogen σ-hole particle using ffTK
T2 - Implementation, testing, and comparison
AU - Pang, Yui Tik
AU - Pavlova, Anna
AU - Tajkhorshid, Emad
AU - Gumbart, James C
N1 - Funding Information:
This work was supported by the National Institutes of Health (Grant Nos. R01-AI148740 to J.C.G. and P41-GM104601 to E.T.) and by Bristol Myers Squibb (to J.C.G.). Computational resources were provided through the Extreme Science and Engineering Discovery Environment (XSEDE; Grant No. TG-MCB130173), which is supported by NSF Grant No. ACI-1548562. The authors also thank Brian Radak for assistance with NAMD.
PY - 2020/10/28
Y1 - 2020/10/28
N2 - Halogen atoms are widely used in drug molecules to improve their binding affinity for the receptor proteins. Many of the examples involve "halogen bonding" between the molecule and the binding site, which is a directional interaction between a halogen atom and a nucleophilic atom. Such an interaction is induced by an electron cloud shift of the halogen atom toward its covalently bonded neighbor to form the σ-bond, leaving a small electrostatic positive region opposite to the bond called the "σ-hole." To mimic the effect of the σ-hole in the CHARMM non-polarizable force field, recently CGenFF added a positively charged massless particle to halogen atoms, positioned at the opposite side of the carbon-halogen bond. This particle is referred to as a lone pair (LP) particle because it uses the lone pair implementation in the CHARMM force field. Here, we have added support for LP particles to ffTK, an automated force field parameterization toolkit widely distributed as a plugin to the molecular visualization software VMD. We demonstrate the updated optimization process using an example halogenated drug molecule, AT130, which is a capsid assembly modulator targeting the hepatitis B virus. Our results indicate that parameterization with the LP particle significantly improves the accuracy of the electrostatic response of the molecule, especially around the halogen atom. Although the inclusion of the LP particle does not produce a prominent effect on the interactions between the molecule and its target protein, the protein-ligand binding performance is greatly improved by optimization of the parameters.
AB - Halogen atoms are widely used in drug molecules to improve their binding affinity for the receptor proteins. Many of the examples involve "halogen bonding" between the molecule and the binding site, which is a directional interaction between a halogen atom and a nucleophilic atom. Such an interaction is induced by an electron cloud shift of the halogen atom toward its covalently bonded neighbor to form the σ-bond, leaving a small electrostatic positive region opposite to the bond called the "σ-hole." To mimic the effect of the σ-hole in the CHARMM non-polarizable force field, recently CGenFF added a positively charged massless particle to halogen atoms, positioned at the opposite side of the carbon-halogen bond. This particle is referred to as a lone pair (LP) particle because it uses the lone pair implementation in the CHARMM force field. Here, we have added support for LP particles to ffTK, an automated force field parameterization toolkit widely distributed as a plugin to the molecular visualization software VMD. We demonstrate the updated optimization process using an example halogenated drug molecule, AT130, which is a capsid assembly modulator targeting the hepatitis B virus. Our results indicate that parameterization with the LP particle significantly improves the accuracy of the electrostatic response of the molecule, especially around the halogen atom. Although the inclusion of the LP particle does not produce a prominent effect on the interactions between the molecule and its target protein, the protein-ligand binding performance is greatly improved by optimization of the parameters.
UR - http://www.scopus.com/inward/record.url?scp=85094643634&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094643634&partnerID=8YFLogxK
U2 - 10.1063/5.0022802
DO - 10.1063/5.0022802
M3 - Article
C2 - 33138412
SN - 0021-9606
VL - 153
SP - 164104
JO - The Journal of Chemical Physics
JF - The Journal of Chemical Physics
IS - 16
M1 - 164104
ER -